Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Kathleen Scholz

Nurse Practitioner, Family Pittsburgh, PA Nurse Practitioner

NPI 1821592643 CMS profile 10778994

127 Anderson St, Pittsburgh, PA 15212

Open in the dashboard

General payments

$396,631

936 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kathleen Scholz of Pittsburgh, PA is reported in the CMS Open Payments database as having received $396,631 across 936 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Nurse Practitioner, Family profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $131,405 242
2024 General $128,101 279
2023 General $59,573 180
2022 General $62,201 186
2021 General $15,352 49

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kathleen Scholz
  • Nurse Practitioner, Family median
  • Middle half of Nurse Practitioner, Family
  • National median

In program year 2025, general payments to Kathleen Scholz were reported at $131,405. Among 107,232 Nurse Practitioner, Family profiles paid that year, the median was $168 and the middle half received between $53 and $521.

Show as a table
Year Kathleen Scholz Nurse Practitioner, Family median Middle half National median
2019 $0 $39 $18–$91 $163
2020 $0 $32 $17–$76 $114
2021 $15,352 $124 $35–$379 $132
2022 $62,201 $141 $44–$430 $149
2023 $59,573 $154 $49–$476 $160
2024 $128,101 $165 $51–$504 $164
2025 $131,405 $168 $53–$521 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Gilead Sciences, Inc. $268,466 661 payments
  2. AbbVie, Inc. $127,286 232 payments
  3. Organogenesis Inc. $250 8 payments
  4. MIMEDX Group, Inc. $153 7 payments
  5. Kerecis Limited $143 9 payments
  6. ViiV Healthcare Company $122 6 payments
  7. BioWound Solutions, Inc. $91 7 payments
  8. Smith+Nephew, Inc. $56 3 payments
  9. Halozyme Inc $24 1 payment
  10. Antares Pharma, Inc. $20 1 payment
  11. Other $18 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $235,609 181 payments
  2. Travel and Lodging $108,401 312 payments
  3. Consulting Fee $33,609 18 payments
  4. Food and Beverage $19,012 425 payments
Products named General payments · program years 2021–2025
  1. Epclusa $252,844 579 payments
  2. MAVYRET $118,849 223 payments
  3. SIMPLIMAX $162 3 payments
  4. Kerecis SurgiClose Wound Care $122 8 payments
  5. Kerecis GraftGuide $122 8 payments
  6. Kerecis SurgiClose Wound Care $122 8 payments
  7. Kerecis SurgiClose Wound Care $122 8 payments
  8. Kerecis SurgiClose Wound Care $122 8 payments
  9. bio-ConneKt $91 7 payments
  10. CABENUVA $63 3 payments
  11. Other $451 21 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

936 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Family in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record